An AllTrials project

NCT06541249: An ongoing trial by Icahn School of Medicine at Mount Sinai

This trial is ongoing. It must report results 2 years, 7 months from now.

Full data

Full entry on ClinicalTrials.gov NCT06541249
Title MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Oct. 2, 2024
Completion date July 31, 2027
Required reporting date July 30, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None